Lewis Gryziewicz
General Counsel bei ANAPTYSBIO, INC.
Profil
Lewis Gryziewicz is currently the Vice President-Regulatory Affairs at AnaptysBio, Inc. He previously held the same position at Macrocure Ltd.
in 2015.
Gryziewicz earned an MBA from Fairleigh Dickinson University in 1996, a doctorate from The University of Colorado in 2006, and an undergraduate degree from the University of the Sciences in Philadelphia in 1986.
Aktive Positionen von Lewis Gryziewicz
| Unternehmen | Position | Beginn |
|---|---|---|
| ANAPTYSBIO, INC. | General Counsel | 01.01.2019 |
Ehemalige bekannte Positionen von Lewis Gryziewicz
| Unternehmen | Position | Ende |
|---|---|---|
| MACROCURE LTD | General Counsel | 31.12.2015 |
Ausbildung von Lewis Gryziewicz
| The University of Colorado | Doctorate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
| University of the Sciences in Philadelphia | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ANAPTYSBIO, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Macrocure Ltd.
 Macrocure Ltd. Medical SpecialtiesHealth Technology Macrocure Ltd. is a clinical-stage biotechnology company, which engages in the development and commercialization of advanced cell therapy products. Its product, CureXcell, is an advanced wound care therapy that treat such wounds by injecting living human white blood cells that have been activate to facilitate the healing process. The company was founded by David Ben-Ami on January 14, 2008 and is headquartered in Petach Tikva, Israel. | Health Technology |
